| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/11/2013 | CN101810583B HIV (Human Immunodeficiency Virus) fusion inhibitor slow-release microsphere |
| 09/11/2013 | CN101808532B Prevention of allergy at weaning |
| 09/11/2013 | CN101735991B Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates |
| 09/11/2013 | CN101686971B Methods of treating multiple myeloma using combination therapies based on anti-cs1 antibodies |
| 09/11/2013 | CN101489591B Peptide compounds for the treatment of hyperexcitability disorders and diseases associated with ion channel dysfunction |
| 09/11/2013 | CN101432294B Compounds analogous to growth hormone peptide secretagogues and preparations containing them |
| 09/11/2013 | CN101356192B Compositions and methods for modulating hemostasis |
| 09/11/2013 | CN101280293B Urate oxidase |
| 09/11/2013 | CN101175768B 促红细胞生成素变体 Erythropoietin variants |
| 09/11/2013 | CN101107006B Methods for treating adhesive capsulitis |
| 09/10/2013 | US8530626 Methods to produce keratin elastomer |
| 09/10/2013 | US8530625 Silk-based drug delivery system |
| 09/10/2013 | US8530621 Combined preparation of a thiazide diuretic and a loop diuretic |
| 09/10/2013 | US8530449 Composition for a topical ophthalmic clear colloidal liquid which undergoes a liquid-gel phase transition in the eye |
| 09/10/2013 | US8530439 Modulation of apolipoprotein C-III expression |
| 09/10/2013 | US8530437 Methods for treating cancer using herpes simplex virus expressing antisense to the squamous cell carcinoma related oncogene |
| 09/10/2013 | US8530432 Methods and compositions for treating conditions |
| 09/10/2013 | US8530431 Treatment of cancers with immunostimulatory HIV TAT derivative polypeptides |
| 09/10/2013 | US8530430 TTK peptides and vaccines including the same |
| 09/10/2013 | US8530428 Treating cancer with granulocyte-macrophage colony stimulating factor |
| 09/10/2013 | US8530427 Methods for modulating resistance to apoptosis using KLK6 |
| 09/10/2013 | US8530425 Targeted delivery of botulinum toxin to the sphenopalatine ganglion |
| 09/10/2013 | US8530424 System and method to improve sensory function |
| 09/10/2013 | US8530423 Anxiolytic compositions containing αs1-casein-derived peptides |
| 09/10/2013 | US8530421 Isolated polypeptides used for treatment of inflammatory diseases and inhibiting cancer metastasis |
| 09/10/2013 | US8530420 Treatment of arthritis with parathyroid hormone |
| 09/10/2013 | US8530419 Process for the synchronization of ovulation for timed breeding without heat detection |
| 09/10/2013 | US8530418 Cytokine containing compositions |
| 09/10/2013 | US8530417 Y-shaped polyethylene glycol modified G-CSF, the preparation and use thereof |
| 09/10/2013 | US8530416 Variants of pigment epithelium derived factor and uses thereof |
| 09/10/2013 | US8530415 Repair and/or regeneration of cells with a composition produced by culturing fibroblast cells under hypoxic conditions |
| 09/10/2013 | US8530414 Antibodies to PCSK9 and uses thereof |
| 09/10/2013 | US8530413 Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
| 09/10/2013 | US8530412 Ejection liquid, ejection method, method of making droplets from liquid, cartridge and ejection device |
| 09/10/2013 | US8530410 Method for treating a keloid with a botulinum toxin |
| 09/10/2013 | US8530407 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
| 09/10/2013 | US8530406 HMG-CoA reductase derived peptide and cosmetic or pharmaceutical composition containing same |
| 09/10/2013 | US8530405 Method of preparing water-soluble and biodegradable antimicrobial agent |
| 09/10/2013 | US8530235 Adjust concentration, and signal passageways activation of bone morphogenic protein |
| 09/10/2013 | US8530234 Hepatitis C virus vaccine |
| 09/10/2013 | US8530225 Therapeutic agents comprising pro-apoptotic proteins |
| 09/10/2013 | US8530214 Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof |
| 09/10/2013 | US8530191 Method for preventing formation of trisulfide derivatives of polypeptides |
| 09/10/2013 | US8530190 Disulfide crosslinked glycoprotein hormone analogs, and their preparation and use |
| 09/10/2013 | US8530189 Sustained drug delivery system |
| 09/10/2013 | US8529951 Elastogenic cues and methods for using same |
| 09/10/2013 | US8529943 Angiopoietin derived peptides |
| 09/10/2013 | US8529940 Dietary method for modulating glucose metabolism |
| 09/10/2013 | US8529939 Purified protein(s) combined with drug(s) and biocompatible solvent(s) to form a coatable mixture; reduction to form a cohesive body or solidified cohesive mass that is formed into a mucoadhesive device havinghomogenous distribution; ovalbumin combined with glycerol; bonding strength |
| 09/10/2013 | US8529922 Polymer formulations for delivery of bioactive materials |
| 09/10/2013 | US8529910 Enterococcus antigens |
| 09/10/2013 | US8529905 Soluble inhibitors of vascular endothelial growth factor and use thereof |
| 09/10/2013 | US8529904 Antigenic peptide comprising sequenc simimlarity to wilm's tumor-1 gene a nd gata-1 transcription factor for use as targeting tools in treatment of cell proliferative disorders; tissue targeted therapy |
| 09/10/2013 | US8529900 Methods for the treatment, the prognostic assessment and the staging of non-small cell lung cancer |
| 09/10/2013 | US8529897 Inflammation-regulating compositions and methods |
| 09/10/2013 | US8529894 Methods of reducing inflammation in cardiomyopathy |
| 09/10/2013 | US8529889 Methods and compositions related to the modulation of intercellular junctions |
| 09/10/2013 | US8529882 Peptidomimetic protease inhibitors |
| 09/10/2013 | US8529881 Peptides for active anti-cytokine immunization |
| 09/10/2013 | US8529871 in a patient receiving high dose radioactive iodine for treatment of cancer; administering to the eyes of said patient an effective amount of perchlorate anion |
| 09/10/2013 | CA2755452C Method of regulating glucose metabolism, and reagents related thereto |
| 09/10/2013 | CA2693296C Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation |
| 09/10/2013 | CA2648473C Impact of calcium phosphate complex on dental caries |
| 09/10/2013 | CA2645763C Calcium phosphate complex in acid containing confectionery |
| 09/10/2013 | CA2627837C Pharmaceutical compositions for alleviating discomfort |
| 09/10/2013 | CA2603332C System and method for loading a beneficial agent into a medical device |
| 09/10/2013 | CA2598823C Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases |
| 09/10/2013 | CA2595894C Percutaneously absorbable preparation, percutaneously absorbable preparation holding sheet, and percutaneously absorbable preparation holding equipment |
| 09/10/2013 | CA2593714C Survivin peptide vaccine |
| 09/10/2013 | CA2569368C Photochromic material comprising a proteorhodopsin apoprotein and retinal analog |
| 09/10/2013 | CA2569367C Composition comprising various proteorhodopsins and/or bacteriorhodopsins and use thereof |
| 09/10/2013 | CA2529027C D-amino acid peptides |
| 09/10/2013 | CA2456247C Use of il-18 inhibitors in hypersensitivity disorders |
| 09/10/2013 | CA2446848C Derivatives of magainin |
| 09/10/2013 | CA2431964C Conjugates of erythropoietin (pep) with polyethylene glycol (peg) |
| 09/10/2013 | CA2413237C Alteration of cell membrane for new functions |
| 09/10/2013 | CA2376693C Immunological control of .beta.-amyloid levels in vivo |
| 09/10/2013 | CA2373753C Preserving a hemoglobin blood substitute with a transparent overwrap |
| 09/10/2013 | CA2338194C Equine system for non-surgical artificial insemination |
| 09/10/2013 | CA2281887C Nucleic acid sequences for atp-binding cassette transporter |
| 09/10/2013 | CA2272245C Stable lyophilized pharmaceutical preparations of monoclonal or polyclonal antibodies |
| 09/06/2013 | WO2013131105A1 Synergistic anti-proliferation activity of tas-108 with mtor inhibitors against cancer cells |
| 09/06/2013 | WO2013131093A1 The use of a panel of urinary cytokines to predict response to bcg therapy for bladder cancer |
| 09/06/2013 | WO2013131091A1 Chimeric fgf21 proteins with enhanced binding affinity for beta-klotho for the treatment of type ii diabetes, obesity and related metabolic disorders |
| 09/06/2013 | WO2013131040A1 Topical gels containing alpha connexin c-terminal (act) peptides |
| 09/06/2013 | WO2013131032A1 Variants of prothymosin alpha and methods of using same |
| 09/06/2013 | WO2013131014A1 Truncated lysosomal acid lipase |
| 09/06/2013 | WO2013130963A1 Compositions and methods for treating type iii gaucher disease |
| 09/06/2013 | WO2013130922A2 Silver based gels for antimicrobial applications |
| 09/06/2013 | WO2013130917A1 Interleukin-3 polypeptide conjugates their uses |
| 09/06/2013 | WO2013130905A1 Antibodies to matrix metalloproteinase 9 |
| 09/06/2013 | WO2013130775A1 Methods for treating patients undergoing multi-cycle chemotherapy |
| 09/06/2013 | WO2013130592A2 Compositions and methods of enhancing weight gain |
| 09/06/2013 | WO2013130577A2 Compositions and methods for the treatment of migraine |
| 09/06/2013 | WO2013130538A2 Method of treating chronic obstructive pulmonary disease |
| 09/06/2013 | WO2013130535A1 Topical delivery of hormonal and non hormonal nano formulations, methods of making and using the same |
| 09/06/2013 | WO2013130349A1 Variants of the lantibiotic mu1140 and other lantibiotics with improved pharmacological properties and structural features |
| 09/06/2013 | WO2013130188A1 Treating human immunodeficiency virus infections |
| 09/06/2013 | WO2013130102A2 Dual ox40 agonist/il-2 cancer therapy methods |
| 09/06/2013 | WO2013129935A1 Use of a particulate immunomodulator in cancer therapy |